Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 6218 

    Article Cited by others

REVIEW ARTICLE

Inflammation and pancreatic cancer: An updated review

Shadhu Kamleshsingh, Xi Chunhua

Year : 2019| Volume: 25| Issue : 1 | Page no: 3-13

   This article has been cited by
 
1 Development and validation of a gene signature for pancreatic cancer: based on inflammatory response–related genes
Manjiang Li, Wei Ding, Yuxu Wang, Yongbiao Ma, Futian Du
Environmental Science and Pollution Research. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Poultry and Fish Intake and Pancreatic Cancer Risk: A Systematic Review and Meta-Analysis
Yu Gao, Yunfei Ma, Mingwei Yu, Guangda Li, Yuhan Chen, Xiaoxiao Li, Xinjie Chen, Ying Xie, Xiaomin Wang
Nutrition and Cancer. 2022; 74(1): 55
[Pubmed]  [Google Scholar] [DOI]
3 Establishment of a reference single-cell RNA sequencing dataset for human pancreatic adenocarcinoma
Ryota Chijimatsu, Shogo Kobayashi, Yu Takeda, Masatoshi Kitakaze, Shotaro Tatekawa, Yasuko Arao, Mika Nakayama, Naohiro Tachibana, Taku Saito, Daisuke Ennishi, Shuta Tomida, Kazuki Sasaki, Daisaku Yamada, Yoshito Tomimaru, Hidenori Takahashi, Daisuke Okuzaki, Daisuke Motooka, Takahito Ohshiro, Masateru Taniguchi, Yutaka Suzuki, Kazuhiko Ogawa, Masaki Mori, Yuichiro Doki, Hidetoshi Eguchi, Hideshi Ishii
iScience. 2022; 25(8): 104659
[Pubmed]  [Google Scholar] [DOI]
4 Exploration of the System-Level Mechanisms of the Herbal Drug FDY003 for Pancreatic Cancer Treatment: A Network Pharmacological Investigation
Ho-Sung Lee, In-Hee Lee, Kyungrae Kang, Sang-In Park, Minho Jung, Seung Gu Yang, Tae-Wook Kwon, Dae-Yeon Lee, Chan-Yen Kuo
Evidence-Based Complementary and Alternative Medicine. 2022; 2022: 1
[Pubmed]  [Google Scholar] [DOI]
5 Prognostic Value of NLR in Patients with Advanced Pancreatic Cancer
? ?
Advances in Clinical Medicine. 2022; 12(11): 10579
[Pubmed]  [Google Scholar] [DOI]
6 Research Progress of Tumor Microenvironment in the Pathogenesis of Pancreatic Cancer
?? ?
Advances in Clinical Medicine. 2022; 12(11): 10625
[Pubmed]  [Google Scholar] [DOI]
7 Prognostic significance of the systemic immune inflammation index in patients with metastatic and unresectable pancreatic cancer
Rongshuang Han, Zibin Tian, Yueping Jiang, Ge Guan, Xiaowei Wang, Xueguo Sun, Yanan Yu, Xue Jing
Frontiers in Surgery. 2022; 9
[Pubmed]  [Google Scholar] [DOI]
8 Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk, Rosa Angela Cardone
Cancers. 2022; 14(10): 2486
[Pubmed]  [Google Scholar] [DOI]
9 Pancreatic Cancer and Microenvironments: Implications of Anesthesia
Hou-Chuan Lai, Yi-Wei Kuo, Yi-Hsuan Huang, Shun-Ming Chan, Kuang-I Cheng, Zhi-Fu Wu
Cancers. 2022; 14(11): 2684
[Pubmed]  [Google Scholar] [DOI]
10 Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening
Mohamed Badheeb, Adham Abdelrahim, Abdullah Esmail, Godsfavour Umoru, Karen Abboud, Ebtesam Al-Najjar, Ghaith Rasheed, Mohammed Alkhulaifawi, Ala Abudayyeh, Maen Abdelrahim
Current Oncology. 2022; 29(11): 8693
[Pubmed]  [Google Scholar] [DOI]
11 Diets, Dietary Patterns, Single Foods and Pancreatic Cancer Risk: An Umbrella Review of Meta-Analyses
Vincenza Gianfredi, Pietro Ferrara, Monica Dinu, Mariateresa Nardi, Daniele Nucci
International Journal of Environmental Research and Public Health. 2022; 19(22): 14787
[Pubmed]  [Google Scholar] [DOI]
12 Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Eleni Karapedi, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou
International Journal of Molecular Sciences. 2022; 23(12): 6664
[Pubmed]  [Google Scholar] [DOI]
13 Serum Metabolomic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African Ancestry
Nnenna Elebo, Jones Omoshoro-Jones, Pascaline N. Fru, John Devar, Christiaan De Wet van Zyl, Barend Christiaan Vorster, Martin Smith, Stefano Cacciatore, Luiz F. Zerbini, Geoffrey Candy, Ekene Emmanuel Nweke
Metabolites. 2021; 11(10): 663
[Pubmed]  [Google Scholar] [DOI]
14 Pancreatic cancer: A review of epidemiology, trend, and risk factors
Jian-Xiong Hu, Cheng-Fei Zhao, Wen-Biao Chen, Qi-Cai Liu, Qu-Wen Li, Yan-Ya Lin, Feng Gao
World Journal of Gastroenterology. 2021; 27(27): 4298
[Pubmed]  [Google Scholar] [DOI]
15 The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology
Arturo Orlacchio, Pellegrino Mazzone
International Journal of Molecular Sciences. 2021; 22(23): 12743
[Pubmed]  [Google Scholar] [DOI]
16 Increased myocellular lipid and IGFBP-3 expression in a pre-clinical model of pancreatic cancer-related skeletal muscle wasting
Calvin L. Cole, John F. Bachman, Jian Ye, Joseph Murphy, Scott A. Gerber, Christopher A. Beck, Brendan F. Boyce, Gowrishankar Muthukrishnan, Joe V. Chakkalakal, Edward M. Schwarz, David Linehan
Journal of Cachexia, Sarcopenia and Muscle. 2021; 12(3): 731
[Pubmed]  [Google Scholar] [DOI]
17 Immunological Effects of Histotripsy for Cancer Therapy
Alissa Hendricks-Wenger, Ruby Hutchison, Eli Vlaisavljevich, Irving Coy Allen
Frontiers in Oncology. 2021; 11
[Pubmed]  [Google Scholar] [DOI]
18 GATA4 Regulates Inflammation-Driven Pancreatic Ductal Adenocarcinoma Progression
Weiliang Jiang, Congying Chen, Li Huang, Jie Shen, Lijuan Yang
Frontiers in Cell and Developmental Biology. 2021; 9
[Pubmed]  [Google Scholar] [DOI]
19 Risk factors of Pancreatic Cancer in Vietnam: A Matched Case–Control Hospital-Based Study
Thuan Van Tran, Tu Van Dao, Khac-Dung Nguyen, To van TA, Khanh Truong Vu, Son Hong Trinh, Hoang Cong Nguyen, Oanh Thi Bui, Quang Tien Nguyen, Hoan Duc Vu, Hiep Le Nguyen, Huong Thanh Tran
Cancer Control. 2021; 28: 1073274821
[Pubmed]  [Google Scholar] [DOI]
20 Impact of sarcopenia on prediction of progression-free survival and overall survival of patients with pancreatic ductal adenocarcinoma receiving first-line gemcitabine and nab-paclitaxel chemotherapy
Tomoya Emori, Masahiro Itonaga, Reiko Ashida, Takashi Tamura, Yuki Kawaji, Keiichi Hatamaru, Yasunobu Yamashita, Toshio Shimokawa, Masataka Koike, Tetsuo Sonomura, Manabu Kawai, Masayuki Kitano
Pancreatology. 2021;
[Pubmed]  [Google Scholar] [DOI]
21 Pancreatic manifestations in rheumatoid arthritis: a national population-based study
Motasem Alkhayyat, Mohannad Abou Saleh, Mehnaj Kaur Grewal, Mohammad Abureesh, Emad Mansoor, C Roberto Simons-Linares, Abby Abelson, Prabhleen Chahal
Rheumatology. 2021; 60(5): 2366
[Pubmed]  [Google Scholar] [DOI]
22 Risk of cancer in patients with recurrent aphthous stomatitis in Korea
Ki Jin Kwon, Su Jin Jeong, Young-Gyu Eun, In Hwan Oh, Young Chan Lee
Medicine. 2021; 100(16): e25628
[Pubmed]  [Google Scholar] [DOI]
23 Comprehensive Analysis of Myoferlin in Human Pancreatic Cancer via Bioinformatics
Rou Pi, Yanmei Chen, Yijie Du, Suzhen Dong, Sercan Ergün
BioMed Research International. 2021; 2021: 1
[Pubmed]  [Google Scholar] [DOI]
24 The effect of medications associated with drug-induced pancreatitis on pancreatic cancer risk: A nested case-control study of routine Scottish data
R.D. McDowell, C.M. Hughes, P. Murchie, C.R. Cardwell
Cancer Epidemiology. 2021; 71: 101880
[Pubmed]  [Google Scholar] [DOI]
25 BML-111, the lipoxin A4 agonist, modulates VEGF or CoCl2-induced migration, angiogenesis and permeability in tumor-derived endothelial cells
Lan Lin, Qingyu Wang, Fen Xu, Xuliang Luo, Jing Xu, Liping Yan, Qing Li, Hua Hao
Immunology Letters. 2021; 230: 27
[Pubmed]  [Google Scholar] [DOI]
26 BML-111 inhibits EMT, migration and metastasis of TAMs-stimulated triple-negative breast cancer cells via ILK pathway
Lan Lin, Xuliang Luo, Lin Wang, Fen Xu, Yuanqiao He, Qingyu Wang, Chunlei Yuan, Jing Xu, Liping Yan, Hua Hao
International Immunopharmacology. 2020; 85: 106625
[Pubmed]  [Google Scholar] [DOI]
27 Leukocyte Telomere Length and Pancreatic Cancer Survival: a Consequence of Activation of IL-6 Signaling Pathway in the Carcinogenic Process?
Raffaella Mormile
Journal of Gastrointestinal Cancer. 2020; 51(2): 720
[Pubmed]  [Google Scholar] [DOI]
28 Combination of xanthohumol and phenethyl isothiocyanate inhibits NF-?B and activates Nrf2 in pancreatic cancer cells
Violetta Krajka-Kuzniak, Marta Cykowiak, Hanna Szaefer, Robert Kleszcz, Wanda Baer-Dubowska
Toxicology in Vitro. 2020; 65: 104799
[Pubmed]  [Google Scholar] [DOI]
29 Biliary Tract Carcinogenesis Model Based on Bile Metaproteomics
Ariel A. Arteta, Miryan Sánchez-Jiménez, Diego F. Dávila, Oscar G. Palacios, Nora Cardona-Castro
Frontiers in Oncology. 2020; 10
[Pubmed]  [Google Scholar] [DOI]
30 From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
Chiara Bazzichetto, Fabiana Conciatori, Claudio Luchini, Francesca Simionato, Raffaela Santoro, Vanja Vaccaro, Vincenzo Corbo, Italia Falcone, Gianluigi Ferretti, Francesco Cognetti, Davide Melisi, Aldo Scarpa, Ludovica Ciuffreda, Michele Milella
Cells. 2020; 9(2): 309
[Pubmed]  [Google Scholar] [DOI]

 

Read this article